Eli Lilly and Company backed the round to support the development of the company's internal pipeline.
"We welcome Lilly as an important shareholder in MiNA. This investment from Lilly, together with our recently announced multi-target research collaboration, represents an important endorsement of our saRNA platform."
The funding round was led by Speedinvest to support the development of novel micro-LED production methods.
"It’s an entirely new engineered GaN material platform to build semiconductor devices on. It offers performance improvements that are suitable for mass production, scalable in wafer size – and crucial for the next generation of microdisplay devices such as AR glasses."
The investment was led by 24Haymarket to fund upcoming trials for the company IL-6 product.
"We are delighted to announce this funding round led by 24 Haymarket. It shows great confidence in our technology and business plan, and will enable us to kick-on in this particularly exciting phase for MediSieve."
Foresight Group has backed NorthWest EHealth with £3m in growth capital.
"The pandemic has strengthened the need for increased data integration to enable rapid trial design, recruitment and remote follow-up. Whilst our software meets many of these needs already, this investment means we can significantly accelerate our development and deployment programmes."